Results 131 to 140 of about 5,787 (176)

EBV+ and Kaposi's Sarcoma Herpesvirus-Associated Multicentric Castleman Disease in a Patient With HIV Infection: A Case Report. [PDF]

Case Rep Infect Dis
Huang MY, Li Z, Zhang W, Chen HY, Liu J, Li CX.   +5 more
europepmc   +1 more source

Comprehensive analysis of subtype-specific outcomes and management in Castleman disease: a 20-year cohort study. [PDF]

Blood Adv
Nishimura Y, Habermann T, Gertz M, Porrata L, Johnston P, Lin Y, Buadi F, Dingli D, Wang Y, Leung N, Kourelis T, Witzig T, Warsame R, Cook J, Rosenthal AC, Sher T, Tun HW, Dispenzieri A.   +17 more
europepmc   +1 more source

Serum interleukin-6 (Il-6) monitoring in idiopathic multicentric Castleman disease: important value in patients receiving non-anti-Il-6 therapy. [PDF]

Biomark Res
Yang ZH, Gao YH, Li SY, Zhang MY, Li AA, Xu HY, Zhang L, Li J.   +7 more
europepmc   +1 more source

Castleman Disease and Kaposi Sarcoma: A Review of the Literature and a Case Series. [PDF]

J Clin Med
Denaro N, Brambilla L, Scarfì F, Tourlaki A, Muscatello A, Solinas C, Rampi N, Bandera A, Garrone O.   +8 more
europepmc   +1 more source

A Case of TAFRO (Thrombocytopenia, Anasarca, Fever or Fibrosis of the Bone Marrow, Renal Dysfunction, and Organomegaly): Exploring the Idiopathic Variant of Multicentric Castleman Disease. [PDF]

Cureus
Parasu T, Gaddam N, Ahmed TR, Parasu A, Palanisamy N.   +4 more
europepmc   +1 more source

Correction: Siltuximab as a first-line therapy for idiopathic multicentric Castleman disease: a retrospective analysis based on the SiMuLa study of the Italian regional network. [PDF]

Front Oncol
Pelliccia S, Di Rocco A, Palumbo G, Zizzari A, Annibali O, Maiolo E, Rago A, Trapè G, Bianchi MP, Pileggi G, Filomeno L, Hohaus S, Rigacci L, Cox MC, Martelli M, La Verde G, Di Napoli A, Tafuri A.   +17 more
europepmc   +1 more source

Multicentric Castleman disease (MCD) presenting with retiform purpura: A rare dermatologic manifestation of a systemic disease. [PDF]

JAAD Case Rep
Kassim S, Jamison A, Warner L, Shinohara MM, Alam M, Cogen AL.   +5 more
europepmc   +1 more source

The sonographic characteristics of unicentric castleman disease - a single-center retrospective study. [PDF]

Cancer Imaging
Liu Z, Niu Z, Gao Y, Xiao M, Wang Y, Zhu Q, Zhang L.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Pathology of Castleman Disease

Hematology/Oncology Clinics of North America, 2018
The term Castleman disease encompasses several distinct lymphoproliferative disorders with different underlying disease pathogenesis, and clinical outcomes. It includes unicentric and multicentric diseases with limited versus significant systemic symptoms, respectively.
David Wu, Megan S Lim, Elaine S Jaffé
exaly   +3 more sources

Castleman disease

Current Opinion in Hematology, 2007
Castleman disease was initially described over 50 years ago as a benign localized mass of lymph nodes found primarily in the mediastinum of asymptomatic patients. Subsequently, additional types were recognized that extend the spectrum of this heterogeneous group of diseases. Optimal standard therapies have not been established. Currently, most patients
Anu, Dham, Bruce A, Peterson
openaire   +4 more sources